Home›Research›Compare›Cartalax vs Leuphasyl
Peptide Comparison
Cartalax vs Leuphasyl
Both are Skin & Joint peptides.
Cartalax
Ala-Glu-Asp-Arg
Half-life: Unknown
4 providers listed
Leuphasyl
Acetyl Tetrapeptide-2
Half-life: N/A (topical)
No providers listed yet
Quick Verdict
Cartalax
Risk
Leuphasyl
Risk
Side-by-Side Comparison
About Cartalax
Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells
A Khavinson peptide bioregulator targeting cartilage tissue. Promotes chondrocyte activity and cartilage matrix regeneration; studied for osteoarthritis and joint degeneration.
Research Areas
About Leuphasyl
Tetrapeptide that mimics enkephalin to modulate facial muscle contraction; competes with enkephalin for opioid receptor sites in neuromuscular junctions; reduces repetitive muscle micro-contractions
A neuromodulating peptide that reduces expression lines via the enkephalin pathway, distinct from SNARE-inhibiting peptides (Argireline, SNAP-8). Complements those actives through a different mechanism.
Research Areas
Find Providers
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More skin joint Comparisons
Browse all peptides →Educational research tools — not medical advice.